BioMark Diagnostics Inc.
BUX
Clasificación en acciones
#26625
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Precio por acción
$0.34495034
Capitalización bursátil
$36.73M
Cambio (1 día)
0.00%
Cambio (1 año)
41.11%
País
CA
Comercio BioMark Diagnostics Inc. (BUX)
Categoría
Healthcare
Ratio P/B de BioMark Diagnostics Inc. (BUX)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de BioMark Diagnostics Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de BioMark Diagnostics Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 4.7411 | - |
US
|
|
| 3.0143 | - |
US
|
|
| 31.051 | - |
US
|
|
| - | - |
CN
|
|
| 6.6641 | - |
US
|
